Tapping Into Japan’s Opportunity in Regenerative Medicine
Cell & gene therapies as well as regenerative medicines (CGT&RMs) have become invaluable tools in the fight against disease. They offer exciting biopharmaceutical opportunities to address the world’s most challenging unmet medical needs.
Interest in CGT&RMs has grown alongside the pharmaceutical and biotechnology industries in recent years; Japan’s established, rapidly expanding market makes it the perfect location to facilitate successful CGT&RM programs.
Discover the benefits of choosing Japan for your CGT&RM product development, manufacture and commercialization.
Download this eBook to learn more about:
- Japan’s well-established CGT&RM market
- An aging population in growing need of novel therapies
- An enabling regulatory environment and governmental investment in CGT&RM success